Alkermes price target raised to $31 from $28 at BofA | Nasdaq

Alkermes Price Target Raised To $31 From $28 At BofA | Nasdaq

2 weeks from now

2 days ago  · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer comps for the ...

nasdaq.com

Alkermes Price Target Raised To $31 From $28 At BofA

2 weeks from now

2 days ago  · BofA raised the firm’s price target on Alkermes (ALKS) to $31 from $28 and keeps a Neutral rating on the shares, citing a higher multiple given the recent move in biotech peer …

businessinsider.com

Alkermes (ALKS) Receives A New Rating From Cantor Fitzgerald

2 weeks from now

Oct 25, 2024  · However, on the same day, H.C. Wainwright reiterated a Hold rating on Alkermes (NASDAQ: ALKS). ... Alkermes price target raised to $31 from $28 at BofA. TipRanks 1d.

businessinsider.com

Maintaining Hold On Alkermes: Weighing Solid Performance …

2 weeks from now

Jul 25, 2024  · Bank of America Securities Keeps Their Hold Rating on Alkermes (ALKS) TipRanks 15h. Alkermes price target raised to $31 from $28 at BofA. TipRanks 15h. ... Nasdaq 100; …

businessinsider.com

Alkermes Price Target Lowered To $28 From $29 At BofA | Nasdaq

2 weeks from now

October 25, 2024 — 10:03 am EDT. BofA analyst Jason Gerberry lowered the firm’s price target on Alkermes (ALKS) to $28 from $29 and keeps a Neutral rating on the shares. The company …

nasdaq.com

Alkermes Plc Stock (ALKS) - Quote Nasdaq- MarketScreener

2 weeks from now

Nov 8, 2024  · Alkermes plc (ALKS.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alkermes plc | Nasdaq: ALKS | Nasdaq ... 28.86 USD-0.38% …

marketscreener.com

6 Analysts Assess Alkermes: What You Need To Know - Nasdaq

2 weeks from now

Jul 15, 2024  · The 12-month price targets, analyzed by analysts, offer insights with an average target of $36.33, a high estimate of $48.00, and a low estimate of $31.00.

nasdaq.com

Alkermes (ALKS) Stock Price, News & Analysis - MarketBeat

2 weeks from now

2 days ago  · Earnings and Valuation 1.9 / 5Proj. Earnings Growth-31.25%. Earnings for Alkermes are expected to decrease by -31.25% in the coming year, from $2.24 to $1.54 per share. The …

marketbeat.com

Alkermes Inc.: Strong Q3 Performance And Strategic Growth Drive …

2 weeks from now

Oct 27, 2024  · The company was founded on May 4, 2011 and is headquartered in Dublin, Ireland. Read More on ALKS: Alkermes price target lowered to $28 from $29 at BofA. …

businessinsider.com

Alkermes (ALKS) Stock Forecast And Price Target 2024 - MarketBeat

2 weeks from now

2 days ago  · According to the 12 analysts' twelve-month price targets for Alkermes, the average price target is $35.42. The highest price target for ALKS is $50.00, while the lowest price …

marketbeat.com

Alkermes Price Target Raised To $40 From $35 At Mizuho | Nasdaq

2 weeks from now

2 days ago  · Mizuho raised the firm’s price target on Alkermes (ALKS) to $40 from $35 and keeps an Outperform rating on the shares. The firm assessed its forecast and conducted a sum-of …

nasdaq.com

Alkermes Stock Price Today (NASDAQ: ALKS) Quote, Market Cap, …

2 weeks from now

Nov 6, 2024  · How much is Alkermes stock worth today? (NASDAQ: ALKS) Alkermes currently has 161,802,508 outstanding shares. With Alkermes stock trading at $28.37 per share, the …

wallstreetzen.com

Buy Rating Affirmed On Alkermes’s Stock Amid Strong Earnings …

2 weeks from now

Jan 25, 2024  · The associated price target is $35.00. Uy Ear of Mizuho Securities has given a Buy rating to Alkermes’s stock based on an anticipated earnings beat and positive 2024 guidance …

businessinsider.com

Alkermes (NASDAQ:ALKS) Given New $40.00 Price Target At …

2 weeks from now

2 days ago  · Piper Sandler reiterated an "overweight" rating and issued a $37.00 price objective (down previously from $38.00) on shares of Alkermes in a research report on Friday, October …

marketbeat.com

Alkermes Price Target Lowered To $30 From $32 At Goldman Sachs

2 weeks from now

Oct 25, 2024  · Goldman Sachs lowered the firm’s price target on Alkermes (ALKS) to $30 from $32 and keeps a Buy rating on the shares. The company’s Q3 results included operating …

nasdaq.com

Alkermes Plc Q3 Profit Increases, But Misses Estimates

2 weeks from now

Oct 24, 2024  · Nasdaq Live; World Map; Commodities ... Alkermes price target raised to $31 from $28 at BofA. TipRanks 7h. Alkermes price target raised to $40 from $35 at Mizuho. TipRanks 9h.

businessinsider.com

Alkermes (ALKS) Earnings Date And Reports 2024 - MarketBeat

2 weeks from now

Alkermes's earnings are expected to decrease from $2.24 per share to $1.54 per share in the next year, which is a -31.25% change. More Earnings Resources from MarketBeat Related …

marketbeat.com

Mizuho Boosts Alkermes (NASDAQ:ALKS) Price Target To $40.00

2 weeks from now

21 hours ago  · Shares of NASDAQ ALKS opened at $28.35 on Wednesday. The company has a market capitalization of $4.59 billion, a P/E ratio of 14.91, a P/E/G ratio of 0.98 and a beta of …

defenseworld.net

Alkermes Buy Rating Affirmed: Profitability And Expansion In ...

2 weeks from now

Jan 29, 2024  · Alkermes price target raised to $29 from $27 at BofA; Alkermes, Armstrong World, National Healthcare, PJT Partners to join S&P 600 ... Alkermes raised to buy by Stifel on …

businessinsider.com

Bank Of America Securities Keeps Their Hold Rating On Alkermes …

2 weeks from now

2 days ago  · Alkermes price target raised to $31 from $28 at BofA; Alkermes price target raised to $40 from $35 at Mizuho; Biotech Alert: Searches spiking for these stocks today; Stifel bullish …

businessinsider.com